POULTRYINDONESIA, Jakarta – The new board members of the Indonesian Veterinary Drug Association (ASOHI) for the 2025–2029 period were officially inaugurated at the Auditorium of Building D, Ministry of Agriculture, on Monday (1/12). The event was held in conjunction with the Coordination Meeting on Veterinary Drug Control and attended by representatives from industry, academia, and government.
The ceremony began with the handover of duties from the outgoing Chair of the ASOHI Supervisory Board (BPA) for the 2021–2025 period, Gani Harijanto, to the newly elected BPA Chair, Drh. Gowinda Sibit. A handover was also conducted between the previous General Chair, Drh. Irawati Fari, and the newly elected General Chair, Drh. Akhmad Harris Priyadi.
After officially assuming the role of BPA Chair, Gowinda conveyed three key messages to the General Chair and the newly appointed board members. First, he emphasized the importance of continuous improvement in the competencies of ASOHI’s leadership to ensure the organization can keep up with the dynamics of the veterinary drug industry.
“Second, it is necessary to encourage all members to comply with government regulations, including Good Manufacturing Practices for Veterinary Drugs (CPOHB), as well as rules related to registration and distribution. Third, strengthening synergy with the government in the oversight of veterinary drugs to safeguard quality, safety, and sustainability of the industry,” he stated.
These messages were positively welcomed by Harris, reflected in his leadership vision to build ASOHI as a professional and facilitative organization that synergizes strongly with all stakeholders, with the aim of advancing Indonesia’s livestock industry to be globally competitive. He also mentioned that holding the inauguration at the Ministry of Agriculture was intended to reaffirm ASOHI’s role as the government’s partner in veterinary drug oversight.
“With regard to veterinary drug oversight, ASOHI contributes through company-based internal monitoring (by producers, importers, and others), as well as community empowerment in monitoring efforts,” he added.
He gave examples such as when the Food and Drug Monitoring Agency (BPOM) requested that human medicines not be used for animals while industries were still adjusting, and cases where certain products were banned but remained in circulation. ASOHI assists the government in monitoring registered products that are still being misused or distributed improperly.
The government, through the Directorate General of Livestock and Animal Health (PKH), represented by Hendra Wibawa as Director of Animal Health, recognized ASOHI as a strategic partner in developing the livestock and animal health sector.
“The veterinary drug industry is one of the key pillars in safeguarding animal health, productivity, food security, and in protecting the public from threatening diseases. Therefore, collaboration between the government as regulator and facilitator with ASOHI must continue to be strengthened under a spirit of public–private synergy,” he said.
To date, regulations and policies in the veterinary drug sector have been consistently aligned with industry dynamics, global developments, and business needs. In addition, veterinary drug exports continue to be facilitated, including guidance on implementing good manufacturing practices and digitalization of veterinary drug services to make processes faster, more transparent, and more efficient.
“With the rapid development of the veterinary drug industry—ranging from product diversification, technological innovation, and formulation, to distribution models—this situation requires an adaptive, risk-based oversight system. We are now entering an era where veterinary drug distribution is not only conducted through conventional channels but also through online platforms, marketplaces, social media, and others, which bring new challenges such as the circulation of illegal or counterfeit veterinary drugs,” he continued.
